GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,311.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,300.00
  • Currency: UK Pounds
  • Shares Issued: 4,145.10m
  • Volume: 1,116,111
  • Market Cap: £54,342m
  • RiskGrade: 129
  • Beta: 0.56

Regulatory News

Director/PDMR Shareholding 19-Nov-2024 15:30 RNS
GLISTEN Trial of Linerixibat Meets Endpoint 19-Nov-2024 07:00 RNS
GSK announces overall survival results for Blenrep 14-Nov-2024 07:00 RNS
Block listing Interim Review 13-Nov-2024 15:00 RNS
Director/PDMR Shareholding 12-Nov-2024 15:30 RNS
GSK publishes provisional 2025 dividend dates 11-Nov-2024 15:01 RNS
Total Voting Rights 01-Nov-2024 15:00 RNS
Director/PDMR Shareholding 30-Oct-2024 14:29 RNS
3rd Quarter Results 30-Oct-2024 07:00 RNS
New positive Arexvy data in younger adults at risk 24-Oct-2024 07:00 RNS
Director/PDMR Shareholding 17-Oct-2024 15:30 RNS
Director/PDMR Shareholding 16-Oct-2024 16:09 RNS
FDA accepts new drug application for gepotidacin 16-Oct-2024 07:00 RNS
Director/PDMR Shareholding 14-Oct-2024 15:30 RNS
Positive results of ANCHOR trials of depemokimab 14-Oct-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,311.00p
Change Today 11.00p
% Change 0.85 %
52 Week High 1,812.50
52 Week Low 1,300.00
Volume 1,116,111
Shares Issued 4,145.10m
Market Cap £54,342m
Beta 0.56
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average
Income
47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 7
Buy 4
Neutral 11
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-24 15-Aug-24
Paid 09-Jan-25 10-Oct-24
Amount 15.00p 15.00p

Trades for 21-Nov-2024

Time Volume / Share Price
12:26 9 @ 1,311.00p
12:26 450 @ 1,311.00p
12:26 734 @ 1,311.50p
12:26 440 @ 1,311.00p
12:26 3,450 @ 1,311.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page